1. Home
  2. ZURA vs IROQ Comparison

ZURA vs IROQ Comparison

Compare ZURA & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • IROQ
  • Stock Information
  • Founded
  • ZURA 2022
  • IROQ 1883
  • Country
  • ZURA United States
  • IROQ United States
  • Employees
  • ZURA N/A
  • IROQ N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • IROQ Savings Institutions
  • Sector
  • ZURA Health Care
  • IROQ Finance
  • Exchange
  • ZURA Nasdaq
  • IROQ Nasdaq
  • Market Cap
  • ZURA 69.9M
  • IROQ 82.7M
  • IPO Year
  • ZURA N/A
  • IROQ 2011
  • Fundamental
  • Price
  • ZURA $1.92
  • IROQ $25.74
  • Analyst Decision
  • ZURA Buy
  • IROQ
  • Analyst Count
  • ZURA 10
  • IROQ 0
  • Target Price
  • ZURA $12.67
  • IROQ N/A
  • AVG Volume (30 Days)
  • ZURA 309.4K
  • IROQ 1.5K
  • Earning Date
  • ZURA 11-06-2025
  • IROQ 11-03-2025
  • Dividend Yield
  • ZURA N/A
  • IROQ 1.56%
  • EPS Growth
  • ZURA N/A
  • IROQ 139.63
  • EPS
  • ZURA N/A
  • IROQ 1.37
  • Revenue
  • ZURA N/A
  • IROQ $26,459,000.00
  • Revenue This Year
  • ZURA N/A
  • IROQ N/A
  • Revenue Next Year
  • ZURA N/A
  • IROQ N/A
  • P/E Ratio
  • ZURA N/A
  • IROQ $18.74
  • Revenue Growth
  • ZURA N/A
  • IROQ 19.82
  • 52 Week Low
  • ZURA $0.97
  • IROQ $18.36
  • 52 Week High
  • ZURA $5.07
  • IROQ $25.97
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 53.10
  • IROQ 54.05
  • Support Level
  • ZURA $1.97
  • IROQ $25.32
  • Resistance Level
  • ZURA $2.19
  • IROQ $25.63
  • Average True Range (ATR)
  • ZURA 0.12
  • IROQ 0.16
  • MACD
  • ZURA -0.15
  • IROQ -1.36
  • Stochastic Oscillator
  • ZURA 84.18
  • IROQ 99.96

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

Share on Social Networks: